Hims stock declined overnight as competitors Eli Lilly and Weight Watchers increased pressure in the weight-loss drug market. Hims' CEO sees potential in Anthropic's latest AI advances for healthcare applications.
Summaries like this, in your inbox every morning.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Vinci4D provides chip-design simulation software that trains on physics equations instead of customer data, an…
SEMI President and CEO Ajit Manocha told DIGITIMES that the semiconductor industry reached the US$1 trillion r…
CoreWeave fell more than 25% this week, its debt yield briefly rose above 16% on Thursday, and SK Hynix droppe…
Nvidia's AI Enterprise lists at $4,500 per GPU annually, and paid subscriptions add supported software, securi…
Anthropic told investors this week that it is making 85% gross margins, a figure the columnist calls a cash co…
Modal Labs, an AI infrastructure provider, raised $750 million in a Series D led by Accel at a $15.75 billion…
